Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 9 Next >
BioMarin (BMRN) Q1 2026 Earnings Transcript
Tickers BMRN
Tags Recent Press Releases BMRN Market News
From Motley Fool
Transcript: Biomarin Pharmaceutical Q1 2026 Earnings Conference Call
Tickers BMRN NEWS
Tags Benzinga News Market News
From Benzinga
BioMarin (BMRN) Q4 2025 Earnings Transcript
Tickers BMRN
Tags Market News BMRN Recent Press Releases
From Motley Fool
Earnings Scheduled For May 4, 2026
Tickers ADCT ADEA ADTN ADUS
Tags PLOW KRYS ALG
From Benzinga
Finding Value in a Shifting Small-Cap Landscape
Tickers AEO ALSN BMRN CART
Tags BMRN allison transmission SFLO
From ETF Trends
Predicting the Next Rule Breaker Buyout
Tickers AAPL ALC AMZN BMRN
Tags AAPL PFE SHOP
From Motley Fool
Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter
Tickers ARM BKNG BMRN CRMD
Tags PINS Benzinga SEC
From Benzinga
Is BioMarin Pharmaceutical Gaining or Losing Market Support?
Tickers BMRN
Tags Short Sellers Trading Ideas BZI/SHORTHIST
From Benzinga
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
Tickers BMRN NEWS
Tags Large Cap BMRN Earnings
From Benzinga
BioMarin (BMRN) Q2 Revenue Jumps 16%
Tickers BMRN
Tags Market News Recent Press Releases BMRN
From Motley Fool
BioMarin (BMRN) Q2 2025 Earnings Call Transcript
Tickers BMRN
Tags Market News BMRN Recent Press Releases
From Motley Fool
Earnings Scheduled For August 4, 2025
Tickers ACM ADTN ADUS AESI
Tags NVTS ALX BGS
From Benzinga
What's Next: Biomarin Pharmaceutical's Earnings Preview
Tickers BMRN
Tags Benzinga BZI/EP BMRN
From Benzinga
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
Tickers BMRN NEWS PTCT
Tags Top Stories Health Care Trading Ideas
From Benzinga
What Does the Market Think About BioMarin Pharmaceutical?
Tickers BMRN
Tags Trading Ideas Short Sellers BZI/SHORTHIST
From Benzinga
Demystifying BioMarin Pharmaceutical: Insights From 4 Analyst Reviews
Tickers BMRN
Tags Analyst Ratings BZI/AAR Benzinga
From Benzinga
Nasdaq Bull Market: 3 Historically Cheap Stocks That Can Easily Double Your Money
Tickers BMRN GT SIRI
Tags GT ^IXIC Recent Press Releases
From Motley Fool
Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs
Tickers BMRN GTLB NEWS OKLO
Tags BMRN SMR News
From Benzinga
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
Tickers BMRN FSLY INTC PFE
Tags PUBM Recent Press Releases SIRI
From Motley Fool
10 Analysts Assess Biomarin Pharmaceutical: What You Need To Know
Tickers BMRN
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
A Look Into Biomarin Pharmaceutical Inc's Price Over Earnings
Tickers BMRN NEWS
Tags Intraday Update Markets BZI/PE
From Benzinga
Earnings Scheduled For May 1, 2025
Tickers AAMI AAPL ABNB ACCO
Tags AJG EOG MTRN
From Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Tickers ABBV AZN BIIB BMRN
Tags Briefs LLY BMY
From Benzinga
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility
Tickers BMRN FSLY INTC PFE
Tags INTC SIRI Recent Press Releases
From Motley Fool
BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients
Tickers BMRN NEWS
Tags Benzinga Biotech Market News
From Benzinga
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
Tickers AMZN BMRN GOOG GOOGL
Tags ^GSPC ^IXIC Recent Press Releases
From Motley Fool
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
Tickers BMRN
Tags Recent Press Releases BMRN Market News
From Motley Fool
Demystifying Biomarin Pharmaceutical: Insights From 8 Analyst Reviews
Tickers BMRN
Tags Market News BMRN Analyst Ratings
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.